Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jimmy D Dikeakos

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
KIM-1/TIM-1 is a Receptor for SARS-CoV-2 in Lung and KidneyYutaro Mori, Corby Fink, Takaharu Ichimura, et al.
Cell Reports|February 17, 2021
Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2Romain Gasser, Marc Cloutier, Jérémie Prévost, et al.
Molecular Biology of the Cell|August 13, 2010
Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef actionJimmy D Dikeakos, Katelyn M Atkins, Laurel Thomas, et al.
Mbio|June 20, 2019
Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell ResponsesJérémie Prévost, Suzanne Pickering, Mitchell J Mumby, et al.
Iscience|October 18, 2022
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and OmicronMehdi Benlarbi, Geneviève Laroche, Corby Fink, et al.
The Lancet. Microbe|March 15, 2025
Association between HIV-1 Nef-mediated MHC-I downregulation and the maintenance of the replication-competent latent viral reservoir in individuals with virally suppressed HIV-1 in Uganda: an exploratory cohort studyMitchell J Mumby, Jessica L Prodger, Jada Hackman, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal EfficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Immunity|August 28, 2021
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Plos Pathogens|December 16, 2021
A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2Gyoung Nyoun Kim, Jung-Ah Choi, Kunyu Wu, et al.
Plos Pathogens|November 29, 2022
Correction: A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2Gyoung Nyoun Kim, Jung-Ah Choi, Kunyu Wu, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
KIM-1/TIM-1 is a Receptor for SARS-CoV-2 in Lung and KidneyYutaro Mori, Corby Fink, Takaharu Ichimura, et al.
Cell Reports|February 17, 2021
Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2Romain Gasser, Marc Cloutier, Jérémie Prévost, et al.
Molecular Biology of the Cell|August 13, 2010
Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef actionJimmy D Dikeakos, Katelyn M Atkins, Laurel Thomas, et al.
Mbio|June 20, 2019
Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell ResponsesJérémie Prévost, Suzanne Pickering, Mitchell J Mumby, et al.
Iscience|October 18, 2022
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and OmicronMehdi Benlarbi, Geneviève Laroche, Corby Fink, et al.
The Lancet. Microbe|March 15, 2025
Association between HIV-1 Nef-mediated MHC-I downregulation and the maintenance of the replication-competent latent viral reservoir in individuals with virally suppressed HIV-1 in Uganda: an exploratory cohort studyMitchell J Mumby, Jessica L Prodger, Jada Hackman, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal EfficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Immunity|August 28, 2021
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Plos Pathogens|December 16, 2021
A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2Gyoung Nyoun Kim, Jung-Ah Choi, Kunyu Wu, et al.
Plos Pathogens|November 29, 2022
Correction: A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2Gyoung Nyoun Kim, Jung-Ah Choi, Kunyu Wu, et al.
Pageof 6